Baker Bros. Advisors as of Dec. 31, 2015
Portfolio Holdings for Baker Bros. Advisors
Baker Bros. Advisors holds 133 positions in its portfolio as reported in the December 2015 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Incyte Corporation (INCY) | 17.5 | $2.1B | 20M | 108.45 | |
Seattle Genetics | 13.9 | $1.7B | 37M | 44.88 | |
Alexion Pharmaceuticals | 10.3 | $1.2B | 6.5M | 190.75 | |
Abbvie (ABBV) | 7.0 | $852M | 14M | 59.24 | |
ACADIA Pharmaceuticals (ACAD) | 6.0 | $730M | 21M | 35.65 | |
Incyte Corp Ltd conv | 4.9 | $596M | 275M | 2.17 | |
Incyte Corp Incy Cvt 144a 0.37 convert | 4.6 | $557M | 259M | 2.15 | |
Genomic Health | 4.0 | $481M | 14M | 35.20 | |
Anacor Pharmaceuticals In | 3.9 | $474M | 4.2M | 112.97 | |
BioMarin Pharmaceutical (BMRN) | 3.6 | $431M | 4.1M | 104.76 | |
Dyax | 2.6 | $313M | 8.3M | 37.62 | |
Dbv Technologies S A | 1.6 | $198M | 5.5M | 36.31 | |
Acorda Therapeutics | 1.3 | $153M | 3.6M | 42.78 | |
Anacor Pharmaceuticals Inc note 2.000%10/1 | 1.3 | $153M | 42M | 3.63 | |
BioCryst Pharmaceuticals (BCRX) | 1.2 | $147M | 14M | 10.32 | |
Biomarin Pharmaceutical Inc note 1.875% 4/2 | 0.9 | $115M | 22M | 5.15 | |
Clovis Oncology Inc note 2.500% 9/1 | 0.9 | $111M | 129M | 0.86 | |
Bellicum Pharma | 0.8 | $99M | 4.9M | 20.27 | |
Gilead Sciences conv | 0.8 | $93M | 21M | 4.46 | |
Mirati Therapeutics | 0.8 | $93M | 3.0M | 31.60 | |
Cerus Corporation (CERS) | 0.7 | $86M | 14M | 6.32 | |
Aquinox Pharmaceuticals | 0.7 | $84M | 6.7M | 12.48 | |
Heron Therapeutics (HRTX) | 0.6 | $78M | 2.9M | 26.70 | |
ImmunoGen | 0.5 | $60M | 4.5M | 13.57 | |
Acorda Therap note 1.75% 6/15 | 0.5 | $59M | 52M | 1.15 | |
Spark Therapeutics | 0.5 | $57M | 1.3M | 45.31 | |
Invitae (NVTAQ) | 0.5 | $54M | 6.6M | 8.21 | |
Neurocrine Biosciences (NBIX) | 0.4 | $48M | 851k | 56.57 | |
Versartis | 0.3 | $40M | 3.2M | 12.39 | |
Sangamo Biosciences (SGMO) | 0.3 | $37M | 4.1M | 9.13 | |
Halozyme Therapeutics (HALO) | 0.3 | $34M | 1.9M | 17.33 | |
Intra Cellular Therapies (ITCI) | 0.3 | $33M | 609k | 53.79 | |
Medivation | 0.3 | $32M | 660k | 48.34 | |
Progenics Pharmaceuticals | 0.2 | $27M | 4.4M | 6.13 | |
Gilead Sciences (GILD) | 0.2 | $25M | 250k | 101.19 | |
Tg Therapeutics (TGTX) | 0.2 | $24M | 2.0M | 11.93 | |
Exelixis Inc cnv | 0.2 | $23M | 20M | 1.16 | |
Galapagos Nv- (GLPG) | 0.2 | $23M | 369k | 62.88 | |
Atyr Pharma Inc Common Stock Usd 0.001 | 0.2 | $23M | 2.3M | 9.83 | |
Idera Pharmaceuticals | 0.2 | $22M | 7.0M | 3.09 | |
Achillion Pharmaceuticals | 0.2 | $22M | 2.0M | 10.79 | |
Catalyst Pharmaceutical Partners (CPRX) | 0.2 | $20M | 8.3M | 2.45 | |
XenoPort | 0.2 | $19M | 3.5M | 5.49 | |
Alkermes (ALKS) | 0.2 | $20M | 250k | 79.38 | |
Array BioPharma | 0.1 | $18M | 4.3M | 4.22 | |
Novavax | 0.1 | $18M | 2.2M | 8.39 | |
Insmed (INSM) | 0.1 | $18M | 1.0M | 18.15 | |
Advanced Accelerat spon ads each rep 2 ord | 0.1 | $18M | 568k | 31.27 | |
Derma Sciences | 0.1 | $17M | 3.8M | 4.57 | |
Foamix Pharmaceuticals | 0.1 | $17M | 2.0M | 8.11 | |
Aegerion Pharmaceuticals 2% Du cvbond | 0.1 | $18M | 27M | 0.66 | |
Biomarin Pharmaceutical Inc note 0.750%10/1 | 0.1 | $16M | 12M | 1.28 | |
Alcobra | 0.1 | $15M | 2.3M | 6.28 | |
Ultragenyx Pharmaceutical (RARE) | 0.1 | $14M | 124k | 112.18 | |
Lion Biotechnologies | 0.1 | $14M | 1.8M | 7.72 | |
Zogenix | 0.1 | $15M | 1.0M | 14.74 | |
Dimension Therapeutics | 0.1 | $14M | 1.2M | 11.28 | |
Xencor (XNCR) | 0.1 | $13M | 872k | 14.62 | |
Global Blood Therapeutics In | 0.1 | $13M | 400k | 32.33 | |
Macrogenics (MGNX) | 0.1 | $11M | 364k | 30.97 | |
Bluebird Bio (BLUE) | 0.1 | $9.1M | 141k | 64.22 | |
Concert Pharmaceuticals I equity | 0.1 | $9.4M | 496k | 18.97 | |
Dermira | 0.1 | $9.5M | 275k | 34.61 | |
Ascendis Pharma A S (ASND) | 0.1 | $9.3M | 506k | 18.32 | |
Ligand Pharmaceuticals In (LGND) | 0.1 | $8.0M | 73k | 108.43 | |
Proqr Thrapeutics N V shs euro (PRQR) | 0.1 | $8.6M | 988k | 8.68 | |
Endocyte | 0.1 | $6.8M | 1.7M | 4.01 | |
Aerie Pharmaceuticals | 0.1 | $7.3M | 299k | 24.35 | |
Ignyta | 0.1 | $7.7M | 571k | 13.40 | |
Curis | 0.1 | $5.8M | 2.0M | 2.91 | |
Arrowhead Research | 0.1 | $6.2M | 1.0M | 6.15 | |
Agios Pharmaceuticals (AGIO) | 0.1 | $6.5M | 100k | 64.92 | |
Sage Therapeutics (SAGE) | 0.1 | $6.1M | 105k | 58.30 | |
Akari Therapeutics | 0.1 | $5.7M | 396k | 14.50 | |
Osiris Therapeutics | 0.0 | $5.2M | 499k | 10.38 | |
Omeros Corporation (OMER) | 0.0 | $5.3M | 336k | 15.73 | |
Medgenics | 0.0 | $4.6M | 765k | 6.02 | |
Trevena | 0.0 | $4.7M | 450k | 10.50 | |
Corsicanto Ltd conv bnd | 0.0 | $4.5M | 5.0M | 0.90 | |
Neuroderm Ltd F | 0.0 | $5.2M | 305k | 17.05 | |
Proteon Therapeutics | 0.0 | $4.6M | 299k | 15.51 | |
Seres Therapeutics (MCRB) | 0.0 | $4.4M | 125k | 35.09 | |
Aimmune Therapeutics | 0.0 | $4.6M | 250k | 18.45 | |
Amarin Corporation (AMRN) | 0.0 | $4.2M | 2.2M | 1.89 | |
Sunesis Pharmaceuticals | 0.0 | $4.0M | 4.5M | 0.90 | |
Epizyme | 0.0 | $3.7M | 233k | 16.02 | |
Vitae Pharmaceuticals | 0.0 | $3.4M | 188k | 18.10 | |
Loxo Oncology | 0.0 | $3.9M | 138k | 28.45 | |
Juno Therapeutics | 0.0 | $3.5M | 80k | 43.98 | |
Nabriva Therapeutics | 0.0 | $3.4M | 350k | 9.62 | |
Ionis Pharmaceuticals (IONS) | 0.0 | $3.5M | 57k | 61.94 | |
Ironwood Pharmaceuticals (IRWD) | 0.0 | $2.0M | 169k | 11.59 | |
Enanta Pharmaceuticals (ENTA) | 0.0 | $2.5M | 75k | 33.02 | |
Mast Therapeutics | 0.0 | $2.0M | 4.8M | 0.42 | |
D Stemline Therapeutics | 0.0 | $2.1M | 334k | 6.31 | |
Array Biopharma Inc note 3.000% 6/0 | 0.0 | $2.8M | 3.0M | 0.94 | |
Ohr Pharmaceutical | 0.0 | $2.3M | 370k | 6.14 | |
Ophthotech | 0.0 | $2.8M | 36k | 78.54 | |
Karyopharm Therapeutics (KPTI) | 0.0 | $2.9M | 217k | 13.25 | |
Flexion Therapeutics | 0.0 | $2.8M | 147k | 19.27 | |
Mediwound Ltd cmn | 0.0 | $1.9M | 225k | 8.54 | |
Immune Design | 0.0 | $3.0M | 149k | 20.08 | |
Assembly Biosciences | 0.0 | $1.9M | 250k | 7.51 | |
Affimed Therapeutics B V | 0.0 | $2.8M | 400k | 7.12 | |
Dynavax Technologies (DVAX) | 0.0 | $1.8M | 75k | 24.16 | |
Protalix Biotherapeutics Inc note 4.500% 9/1 | 0.0 | $2.4M | 3.4M | 0.69 | |
Trillium Therapeutics, Inc. Cmn | 0.0 | $2.7M | 212k | 12.61 | |
Pronai Therapeutics | 0.0 | $3.0M | 200k | 15.04 | |
Natera (NTRA) | 0.0 | $2.7M | 250k | 10.80 | |
Alnylam Pharmaceuticals (ALNY) | 0.0 | $1.1M | 11k | 94.18 | |
BioDelivery Sciences International | 0.0 | $1.0M | 210k | 4.79 | |
Palatin Technologies | 0.0 | $1.4M | 2.1M | 0.66 | |
Discovery Laboratories | 0.0 | $750k | 3.6M | 0.21 | |
Cytrx | 0.0 | $1.7M | 660k | 2.65 | |
Chimerix (CMRX) | 0.0 | $1.0M | 115k | 8.95 | |
Acceleron Pharma | 0.0 | $1.4M | 29k | 48.77 | |
Five Prime Therapeutics | 0.0 | $799k | 19k | 41.51 | |
Aldeyra Therapeutics (ALDX) | 0.0 | $963k | 142k | 6.78 | |
Aurinia Pharmaceuticals (AUPH) | 0.0 | $1.8M | 712k | 2.51 | |
Marinus Pharmaceuticals | 0.0 | $1.5M | 200k | 7.64 | |
Tenax Therapeutics | 0.0 | $1.4M | 420k | 3.28 | |
Cellectis S A (CLLS) | 0.0 | $1.6M | 50k | 31.04 | |
Adaptimmune Therapeutics (ADAP) | 0.0 | $1.2M | 100k | 12.06 | |
Arbutus Biopharma (ABUS) | 0.0 | $804k | 181k | 4.45 | |
Ritter Pharmaceuticals | 0.0 | $680k | 400k | 1.70 | |
Cyclacel Pharmaceuticals Inc pfd conv ex 6% (CYCCP) | 0.0 | $52k | 13k | 3.92 | |
Chemocentryx | 0.0 | $397k | 49k | 8.09 | |
Foundation Medicine | 0.0 | $440k | 21k | 21.06 | |
La Jolla Pharmaceuticl Com Par | 0.0 | $371k | 14k | 26.99 | |
Achaogen | 0.0 | $574k | 100k | 5.74 | |
Uniqure Nv (QURE) | 0.0 | $496k | 30k | 16.53 | |
Biotime Inc wts oct 1 18 | 0.0 | $24k | 20k | 1.19 | |
Aptose Biosciences | 0.0 | $84k | 33k | 2.52 |